Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 12Thoracic 8Dermatologic 7Other hematologic neoplasm 4Genitourinary 4Tumor-Agnostic 3Lymphoid 3Other 2Myeloid 2Breast 2Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Mesothelioma 1

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 126Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Specimen Handling 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fecal Microbiota Transplantation × Other solid neoplasm × Clear all
NCT04056026 2019-09-23

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

ProgenaBiome

Phase EARLY_PHASE1 Completed
1 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡